Fatigue affects roughly 8-12% of Retatrutide users, typically peaking during weeks 4 through 10 of treatment
Under the GLP-1 class framing, it is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2, anyone pregnant or breastfeeding, and anyone with prior serious GLP-1 hypersensitivity
RCTs evaluating GLP-1 RA have not identified indicators of suicidality
These adverse effects are expected to be closely tracked through additional Phase 3 clinical trials scheduled for this year.reakdown and enabling the body to burn more calories
With the right combination of injectables, bio-stimulatory treatments, advanced technology, and medical-grade skincare, patients can achieve natural, confidence-boosting results without surgery
GLP-1 is a natural hormone made in the gut thats released after we eat